BIOLinks
British Columbia BIO Links LifeSciences British Columbia

Welichem Appoints Business Development Manager
Welichem Biotech Inc. is delighted to announce the appointment of Dr. Yan Chen as Business Development Manager.

J. William Freytag, PH.D. appointed Chairman and Chief Executive Officer of Aspreva Pharmaceuticals
Aspreva Pharmaceuticals Corporation announced the appointment of Dr. J. William Freytag as Chairman and Chief Executive Officer, succeeding Richard Glickman, one of Aspreva’s founders and the company’s first Chairman and CEO.

Neuromed Appoints Dr. William L. Hunter as Chairman of the Board of Directors
Neuromed Pharmaceuticals, a biopharmaceutical company developing new and improved chronic pain drugs, announced today that Dr. William L. Hunter has been appointed Chairman of Neuromed's Board of Directors. Dr. Hunter is co-founder and President and CEO of Angiotech Pharmaceuticals, Inc. and has served as a Director on Neuromed's Board since 2004.

Genome BC Welcomes New Communications Officer
Julia White has joined Genome British Columbia as Communications Officer. She brings extensive communications and event management experience to the position. Julia joins the organization from The University of British Columbia where she has been for more than five years, lately as Events and Marketing Manager in the Office of Community Affairs.

UVIC's Vancouver Island Tech Park Appoints New Manager of Business Development and Marketing
Av Hundle, a recent University of Victoria business grad, is the new Manager, Business Development and Marketing at UVic’s Vancouver Island Technology Park (VITP) in Saanich.

Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2